Subscribe to RSS
DOI: 10.1055/s-0032-1328076
18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi
18-jährige Patientin mit Erstdiagnose eines embryonalen Rhabdomyosarkoms des Uterus in statu nascendiPublication History
received 21 November 2012
revised 03 December 2012
accepted 04 December 2012
Publication Date:
19 December 2012 (online)
Abstract
Background: We report a case of an 18-year-old woman with an embryonal rhabdomyosarcoma in statu nascendi. Case: A fist-sized embryonal rhabdomyosarcoma of the uterus filling the vaginal vault was diagnosed in an adolescent with virgo intacta suffering from therapy resistant vaginal discharge, bleeding and bulging mass for six months. Further imaging revealed one suspicious pelvine lymph node. Excision of the tumour including the intracervical stalk was performed and followed by systemic multiagent chemotherapy. PET-CT scan presented a complete response after the third cycle. Histological complete response was shown by laparoscopic dissection of regional pelvic lymph nodes and curettage. Conclusion: Uterine Rhabdomyosarcoma should be considered as differential diagnosis of therapy resistant vaginal flour and bleeding in young women. Fertility-sparing therapy is possible in selected exceptional cases.
Zusammenfassung
Hintergrund: Wir berichten über eine 18-jährige Patientin mit Erstdiagnose eines embryonalen Rhabdomyosarkoms des Uterus in statu nascendi. Fallbericht: Bei einer 18-jährigen Patientin G0, virgo intacta fiel ein übelriechender, zerfallender Tumor im Bereich der Scheide auf. Die durchgeführte Biopsie zeigte einen malignen mesenchymalen Tumor mit Verdacht auf embryonales Rhabdomyosarkom. Bei starker vaginaler Blutung wurde am Aufnahmetag ein MRT des Beckens durchgeführt. Hier wurde ebenfalls der Verdacht auf ein Leiomyosarkom ausgehend von der Vagina mit Zervixbeteiligung und zusätzlich eines metastasensuspekten Lymphknoten rechts pelvin diagnostiziert. Nach vaginaler Partialexzision des Primarius wurde mit systemischer Chemotherapie begonnen. Die Reevaluation mittels PET-CT nach dem 3. Zyklus der systemischen Therapie zeigte eine ycT0-ycN0-cM0-Situation. Die Komplettremission konnte durch laparoskopisch durchgeführte pelvine Lymphnodektomie rechts und fraktionierte Kürettage histologisch bestätigt werden. Fazit: Bei den jungen Patientinnen mit therapieresistenten vaginalen Fluor und Blutungen sollte bei der Differenzialdiagnose an ein uterines Rhabdomyosarkom gedacht werden. In Ausnahmefällen kann die Tumortherapie auch fertilitätserhaltend durchgeführt werden.
-
References
- 1 Ferguson SE, Gerald W, Barakat RR et al. Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. Am J Surg Pathol 2007; 31: 382-389
- 2 da Silva BB, Dos Santos AR, Bosco Parentes-Vieira J et al. Embryonal rhabdomyosarcoma of the uterus associated with uterine inversion in an adolescent: a case report and published work review. J Obstet Gynaecol Res 2008; 34 (4 Pt 2) 735-738
- 3 Perrone T, Carson LF, Dehner LP. Rhabdomyosarcoma with heterologous cartilage of the uterine cervixa clinicopathologic and immunohistochemical study of an aggressive neoplasm in a young female. Med Pediatr Oncol 1990; 18: 72-76
- 4 Copeland LJ, Sneige N, Stringer A et al. Alveolar rhabdomyosarcoma of the female genitalia. Cancer 1985; 56: 849-855
- 5 Montag TWD, Ablaing G, Schlaerth JB et al. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol 1986; 25: 171-194
- 6 Zeisler H, Mayerhofer K, Joura EA et al. Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 1998; 69: 78-83
- 7 Brand E, Berek JS, Nieberg RK et al. Rhabdomyosarcoma of the uterine cervix. Sarcoma botryoides. Cancer 1987; 60: 1552-1560
- 8 Scaravilli G, Simeone S, DellʼAversana Orabona G et al. Case report of a sarcoma botryoides of the uterine cervix in fertile age and literature review. Arch Gynecol Obstet 2009; 280: 863-866
- 9 Hilgers RD, Malkasian GD, Soule EH. Embryonal rhabdomyosarcoma (botryoid type) of the vaginaa clinicopathologic review. Am J Obstet Gynecol 1970; 107: 484-502
- 10 Heyn RM, Holland R, Newton jr. WA et al. The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children. Cancer 1974; 634: 2128-2142
- 11 Kumar APM, Wern EL, Fleming ID et al. Combined therapy to prevent complete exenteration for rhabdomyosarcoma of the vagina or uterus. Cancer 1976; 37: 118-122
- 12 Copeland LJ, Gershenson DM, Saul PB et al. Sarcoma botryoides of the female genital tract. Obstet Gynecol 1985; 66: 262-266
- 13 Gordon AN, Montag TW. Sarcoma botryoides of the cervix: excision followed by adjuvant chemotherapy for preservation of reproductive function. Gynecol Oncol 1990; 36: 119-124
- 14 Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol 1988; 29: 290-304
- 15 Cooperative Weichteilsarkom Study Group CWS der GPOH in cooperation with the European paediatric Soft Tissue Sarcoma Study Group. EpSSG CWS-guidance for risk adapted treatment of soft tissue sarcoma and soft tissue tumours in children, adolescents, and young adults. Version 1.5. from 1.7.2009,. http://www.kinderkrebsinfo.de/e9031/e10591/e77084/e110986/index_ger.html
- 16 Behtash N, Mousavi A, Tehranian A et al. Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 2003; 91: 452-455
- 17 Donaldson SS, Meza J, Breneman JC et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma–a report from the IRSG. Int J Radiat Oncol Biol Phys 2001; 51: 718-728
- 18 Kayton ML, Wexler LH, Lewin SN et al. Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy. J Pediatr Surg 2009; 44: 862-867
- 19 Bernal KL, Fahmy L, Remmenga S et al. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol 2004; 95: 243-246